Beijing Aosaikang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Beijing Aosaikang Pharmaceutical has a total shareholder equity of CN¥3.1B and total debt of CN¥92.0M, which brings its debt-to-equity ratio to 2.9%. Its total assets and total liabilities are CN¥4.0B and CN¥829.2M respectively. Beijing Aosaikang Pharmaceutical's EBIT is CN¥35.2M making its interest coverage ratio -1.6. It has cash and short-term investments of CN¥2.1B.
Key information
2.9%
Debt to equity ratio
CN¥92.03m
Debt
| Interest coverage ratio | -1.6x |
| Cash | CN¥2.08b |
| Equity | CN¥3.13b |
| Total liabilities | CN¥829.24m |
| Total assets | CN¥3.96b |
Recent financial health updates
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt Sensibly?
Oct 11
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?
Apr 29Recent updates
Optimistic Investors Push Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE:002755) Shares Up 35% But Growth Is Lacking
Oct 18Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt Sensibly?
Oct 11Beijing Aosaikang Pharmaceutical's (SZSE:002755) Earnings Are Weaker Than They Seem
Sep 05Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) 26% Price Boost Is Out Of Tune With Revenues
May 21Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?
Apr 29There's Reason For Concern Over Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Massive 27% Price Jump
Mar 13Financial Position Analysis
Short Term Liabilities: 002755's short term assets (CN¥2.6B) exceed its short term liabilities (CN¥751.5M).
Long Term Liabilities: 002755's short term assets (CN¥2.6B) exceed its long term liabilities (CN¥77.7M).
Debt to Equity History and Analysis
Debt Level: 002755 has more cash than its total debt.
Reducing Debt: 002755's debt to equity ratio has increased from 0% to 2.9% over the past 5 years.
Debt Coverage: 002755's debt is well covered by operating cash flow (467.7%).
Interest Coverage: 002755 earns more interest than it pays, so coverage of interest payments is not a concern.